PharmaMar, Globant collaborate to accelerate oncology research with AI

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Two lawsuits filed within days of each other in the U.S. District Court for the Northern District of Illinois claim that Tempus AI Inc. had violated the Illinois Genetic Information Privacy Act when it acquired Ambry Genetics and started to integrate its genetics data into its predictive models.

Siemens Healthineers and Mayo Clinic collaborate to improve care for neurodegenerative disease, cancer

Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors.

February 20, 2026

Vol.52 No.07

Clinical Roundup

AI tool may help personalize ovarian cancer treatment from day one

Researchers from the University of Minnesota Medical School, in collaboration with Emory University and the Georgia Institute of Technology, have developed a new artificial intelligence biomarker tool that may help predict how ovarian cancer patients will respond to treatment at the time of diagnosis.

February 13, 2026

Vol.52 No.06

Clinical Roundup

Most patients support use of AI to help read mammograms with doctor oversight, UTSW survey finds

UT Southwestern Medical Center researchers found that most patients support the use of AI to help interpret mammograms as long as radiologists provide oversight in the imaging analysis, although perceptions varied among patient populations.

January 30, 2026

Vol.52 No.04

Drugs & Targets

Labcorp and Roche collaborate to expand access to advanced precision testing

Labcorp announced its first U.S. commercial laboratory with an agreement to implement Roche’s cobas Mass Spec solution. This collaboration introduces fully automated mass spectrometry into routine clinical practice—accelerating turnaround times, improving accuracy, and expanding access to advanced diagnostics for patients and providers nationwide.

January 30, 2026

Vol.52 No.04

Drugs & Targets

HanchorBio and WuXi Biologics form partnership to advance next-generation bi-and multi-functional fusion protein pipeline

HanchorBio, a global clinical-stage biotechnology company, and WuXi Biologics, a global Contract Research, Development, and Manufacturing Organization, jointly announced the signing of a strategic collaboration agreement to support the development and manufacturing of multiple next-generation bi- and multi-functional fusion programs from HanchorBio’s pipeline.

January 30, 2026

Vol.52 No.04

PharmaMar, Globant collaborate to accelerate oncology research with AI

YOU MAY BE INTERESTED IN

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Siemens Healthineers and Mayo Clinic collaborate to improve care for neurodegenerative disease, cancer

AI tool may help personalize ovarian cancer treatment from day one

Most patients support use of AI to help read mammograms with doctor oversight, UTSW survey finds

Labcorp and Roche collaborate to expand access to advanced precision testing

HanchorBio and WuXi Biologics form partnership to advance next-generation bi-and multi-functional fusion protein pipeline

Renew today!

Subscriber content

Never miss an issue!

Login

PharmaMar, Globant collaborate to accelerate oncology research with AI

YOU MAY BE INTERESTED IN

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE“Deidentified” ≠ “deidentifiable”

Siemens Healthineers and Mayo Clinic collaborate to improve care for neurodegenerative disease, cancer

AI tool may help personalize ovarian cancer treatment from day one

Most patients support use of AI to help read mammograms with doctor oversight, UTSW survey finds

Labcorp and Roche collaborate to expand access to advanced precision testing

HanchorBio and WuXi Biologics form partnership to advance next-generation bi-and multi-functional fusion protein pipeline

Never miss an issue!

Login

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”